Target intelligence / Profile preview

HIV-related genes

Molecular classification
Enzyme, Regulatory protein, Structural protein, Receptor, Transcription factor, Other signaling proteins
01

Overview

HIV-related genes represent a broad array of genetic elements encompassing both viral and host cellular genes—such as HIV-1 structural (Pol, Gag, Env), regulatory (Tat, Rev, Nef), and accessory genes (Vpu, Vif), as well as host factors including CD4, CCR5, CXCR4, and various cellular co-factors involved in HIV replication and immune response. These genes are key therapeutic and research targets for anti-HIV strategies ranging from receptor blockade (e.g., CCR5 inhibitors such as maraviroc) to genome editing (using ZFNs, CRISPR/Cas9, TALENs) and RNA interference technologies targeting both viral genetic material and essential host factors. The term is not specific to a single molecule but encapsulates multiple critical pathways and mechanisms relevant to HIV pathology and therapy. For structured data curation, referencing individual gene products is strongly recommended rather than the umbrella term "HIV-related genes."

Other names
HIV genesHIV host genesHIV viral genesHIV-associated genesHIV target genes
02

Mechanism of action

Blockade of cell entry receptors (CCR5, CXCR4, CD4); Gene disruption/editing to inactivate viral or host genes critical for HIV replication (e.g., CCR5 knockout, LTR inactivation); RNA interference with critical viral transcripts or essential host cofactors

03

Biological functions

Immune responseCell entry (membrane fusion)Viral replicationLatency and transcriptional regulationApoptosisCell proliferation
04

Disease associations

InfectionOther
05

Safety considerations

Potential genotoxicity from genome editing technologies (off-target mutations)Immune escape from targeting single or limited viral genes due to high mutation ratesEmergence of dual/multiple tropic viruses bypassing blocked receptorsEffects of host gene targeting on normal cellular function and immune response
06

Interacting drugs

Maraviroc

4 more in the full profile.

07

Biomarkers

CD32aCD4 levelsCCR5 genotype (Δ32)Viral load (e.g., HIV-1 RNA, p24 antigen)

Beyond the preview

Go deeper on HIV-related genes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HIV-related genes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call